Advertisement

Ads Placeholder
Loading...

Aurora Cannabis Inc.

21P1.FXETRA
Healthcare
Drug Manufacturers - Specialty & Generic
0.36
-0.01(-2.86%)
German Market opens in 1h 5m

Aurora Cannabis Inc. Fundamental Analysis

Aurora Cannabis Inc. (21P1.F) shows weak financial fundamentals with a PE ratio of -0.43, profit margin of -25.65%, and ROE of -13.26%. The company generates $0.3B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position636.43%
PEG Ratio-0.00
Current Ratio3.42

Areas of Concern

ROE-13.26%
Operating Margin-17.19%
We analyze 21P1.F's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -8.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-8.6/100

We analyze 21P1.F's fundamental strength across five key dimensions:

Efficiency Score

Weak

21P1.F struggles to generate sufficient returns from assets.

ROA > 10%
-8.27%

Valuation Score

Excellent

21P1.F trades at attractive valuation levels.

PE < 25
-0.43
PEG Ratio < 2
-0.00

Growth Score

Weak

21P1.F faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

21P1.F maintains a strong and stable balance sheet.

Debt/Equity < 1
0.19
Current Ratio > 1
3.42

Profitability Score

Weak

21P1.F struggles to sustain strong margins.

ROE > 15%
-1325.74%
Net Margin ≥ 15%
-25.65%
Positive Free Cash Flow
No

Key Financial Metrics

Is 21P1.F Expensive or Cheap?

P/E Ratio

21P1.F trades at -0.43 times earnings. This suggests potential undervaluation.

-0.43

PEG Ratio

When adjusting for growth, 21P1.F's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Aurora Cannabis Inc. at 0.05 times its book value. This may indicate undervaluation.

0.05

EV/EBITDA

Enterprise value stands at -3.26 times EBITDA. This is generally considered low.

-3.26

How Well Does 21P1.F Make Money?

Net Profit Margin

For every $100 in sales, Aurora Cannabis Inc. keeps $-25.65 as profit after all expenses.

-25.65%

Operating Margin

Core operations generate -17.19 in profit for every $100 in revenue, before interest and taxes.

-17.19%

ROE

Management delivers $-13.26 in profit for every $100 of shareholder equity.

-13.26%

ROA

Aurora Cannabis Inc. generates $-8.27 in profit for every $100 in assets, demonstrating efficient asset deployment.

-8.27%

Following the Money - Real Cash Generation

Operating Cash Flow

Aurora Cannabis Inc. generates limited operating cash flow of $-72.89M, signaling weaker underlying cash strength.

$-72.89M

Free Cash Flow

Aurora Cannabis Inc. generates weak or negative free cash flow of $-90.93M, restricting financial flexibility.

$-90.93M

FCF Per Share

Each share generates $-1.67 in free cash annually.

$-1.67

FCF Yield

21P1.F converts -2.71% of its market value into free cash.

-2.71%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.43

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.05

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.12

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.19

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.42

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.13

vs 25 benchmark

ROA

Return on assets percentage

-0.08

vs 25 benchmark

ROCE

Return on capital employed

-0.07

vs 25 benchmark

How 21P1.F Stacks Against Its Sector Peers

Metric21P1.F ValueSector AveragePerformance
P/E Ratio-0.4328.54 Better (Cheaper)
ROE-13.26%738.00% Weak
Net Margin-25.65%-43982.00% (disorted) Weak
Debt/Equity0.190.34 Strong (Low Leverage)
Current Ratio3.422806.01 Strong Liquidity
ROA-8.27%-14624.00% (disorted) Weak

21P1.F outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Aurora Cannabis Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ